These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Relationship of relative inhibitor potency to magnitude of challenge. I. Phenothiazine suppression of pecking syndromes of varying intensity. BURKMAN AM Arch Int Pharmacodyn Ther; 1962 Jun; 137():404-9. PubMed ID: 13874905 [No Abstract] [Full Text] [Related]
23. [Inhibition of crystallized D-glyceraldehyde-3-phosphate dehydrogenase activity by phenothiazine and aminoketone]. WOLLEMANN M; ELODI P Biochem Pharmacol; 1961 Jun; 6():228-32. PubMed ID: 13786410 [No Abstract] [Full Text] [Related]
24. [RELATIONSHIP BETWEEN CHEMICAL CONSTITUTION AND CARDIOVASCULAR ACTIVITY OF THERAPEUTICALLY APPLIED PHENOTHIAZINE AND THIAXANTHENE DERIVATIVES. 1]. HAMACHER J; HILDEBRANDT G Arzneimittelforschung; 1964 Sep; 14():977-81. PubMed ID: 14344170 [No Abstract] [Full Text] [Related]
25. [ON THE ANTI-TREMORINE EFFECT OF QUATERNARY PHENOTHIAZINE DERIVATIVES]. NOWAK R; FEMMER K Acta Biol Med Ger; 1964; 13():358-68. PubMed ID: 14251832 [No Abstract] [Full Text] [Related]
26. [Pharmacology and use of phenothiazine derivatives]. WESTERINK D Pharm Weekbl; 1956 Feb; 91(4):113-25. PubMed ID: 13310219 [No Abstract] [Full Text] [Related]
27. [The phenothiazines]. CHINI F Minerva Farm; 1960 May; 9():75-6. PubMed ID: 13809880 [No Abstract] [Full Text] [Related]
28. Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butvrophenone. JANSSEN PA; NIEMEGEERS CJ Arzneimittelforschung; 1959 Dec; 9():765-7. PubMed ID: 14406751 [No Abstract] [Full Text] [Related]
29. Relative potencies of some phenothiazines as pecking syndrome inhibitors. BURKMAN AM J Pharm Sci; 1961 Sep; 50():771-3. PubMed ID: 13689104 [No Abstract] [Full Text] [Related]
30. [Pharmacology of N-piperidinoalkyl-phenothiazine]. NIESCHULZ O; POPENDIKER K Arzneimittelforschung; 1955 Aug; 5(8):458-60. PubMed ID: 13276251 [No Abstract] [Full Text] [Related]
31. [On the significance of various pharmacodynamic properties of phenothiazine derivatives in relation to their clinical efficacy]. TAESCHLER M; FANCHAMPS A; CERLETTI A Psychiatr Neurol (Basel); 1960; 139():85-104. PubMed ID: 13836566 [No Abstract] [Full Text] [Related]
32. Studies on experimental shock; effects of vasopressor amines and phenothiazine derivatives. BRUNSON JG; KALINA RE; ECKMAN PL Am J Pathol; 1959; 35(6):1149-67. PubMed ID: 13805392 [No Abstract] [Full Text] [Related]
33. [Contribution to the in vitro effect of phenothiazines on the activity of ribonuclease]. KUSCH T; HEINRICH I; HOFMANN H Acta Biol Med Ger; 1962; 8():439-41. PubMed ID: 14460872 [No Abstract] [Full Text] [Related]
34. [Experimental catatonia induced by neuroleptic drugs. I. Action of phenothiazine derivatives]. ALEMA G; GIANNIOTTI G; ROSADINI G Boll Soc Ital Biol Sper; 1961 Oct; 37():1037-40. PubMed ID: 13860287 [No Abstract] [Full Text] [Related]
35. A contribution to the pharmacology of chlorpromazine and 10-(3'-dimethylaminopropyl)-phenothiazine. VAN PROOSDIJ-HARTZEMA EG Acta Physiol Pharmacol Neerl; 1955 Nov; 4(3):378-87. PubMed ID: 13301802 [No Abstract] [Full Text] [Related]
37. [On the relationship between the ataractic and other types of central effects of some phenothiazine derivatives]. LIUBIMOV BI; RAEVSKII KS Farmakol Toksikol; 1962; 25():24-7. PubMed ID: 14465967 [No Abstract] [Full Text] [Related]
38. [On the effect of neuroplegic substances on the chemoreception]. VIKHLIAEV IuI Uch Zap Inst Farmakol Khimioter AMN SSSR; 1960; 2():114-20. PubMed ID: 13925911 [No Abstract] [Full Text] [Related]
39. [Pharmacological studies on 10-(1-methyl-3-piperidyl)-2-methoxyphenothiazine and related compounds]. NIESCHULZ O; HOFFMANN I; POPENDIKER K Arzneimittelforschung; 1960 Mar; 10():156-65. PubMed ID: 14427122 [No Abstract] [Full Text] [Related]